U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
U.S. Physical Therapy Stock Performance
Shares of NYSE:USPH traded up $1.94 during midday trading on Thursday, reaching $91.48. 105 shares of the company's stock traded hands, compared to its average volume of 101,112. The company has a market cap of $1.19 billion, a price-to-earnings ratio of 30.56 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.08 and a current ratio of 1.43. U.S. Physical Therapy has a one year low of $84.43 and a one year high of $131.50. The stock has a 50 day moving average of $113.37 and a 200 day moving average of $104.74.
U.S. Physical Therapy (NYSE:USPH - Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.90 EPS for the quarter, missing analysts' consensus estimates of $0.93 by ($0.03). U.S. Physical Therapy had a return on equity of 14.22% and a net margin of 7.62%. The company had revenue of $140.70 million during the quarter, compared to analysts' expectations of $143.01 million. During the same quarter in the previous year, the company earned $0.96 EPS. The business's quarterly revenue was up 10.9% compared to the same quarter last year. As a group, equities research analysts anticipate that U.S. Physical Therapy will post 2.7 EPS for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 16th. Stockholders of record on Thursday, August 18th will be issued a $0.41 dividend. The ex-dividend date is Wednesday, August 17th. This represents a $1.64 annualized dividend and a dividend yield of 1.79%. U.S. Physical Therapy's payout ratio is 55.97%.
Wall Street Analyst Weigh In
Separately, TheStreet upgraded U.S. Physical Therapy from a "c+" rating to a "b-" rating in a research report on Thursday, July 28th.
Insiders Place Their Bets
In related news, Director Anne Motsenbocker purchased 500 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were acquired at an average cost of $92.29 per share, for a total transaction of $46,145.00. Following the acquisition, the director now owns 2,600 shares of the company's stock, valued at approximately $239,954. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, Director Anne Motsenbocker acquired 500 shares of the firm's stock in a transaction dated Tuesday, August 9th. The stock was acquired at an average price of $92.29 per share, with a total value of $46,145.00. Following the acquisition, the director now directly owns 2,600 shares in the company, valued at approximately $239,954. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Graham D. Reeve sold 3,818 shares of U.S. Physical Therapy stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $92.24, for a total value of $352,172.32. Following the completion of the transaction, the chief operating officer now owns 16,191 shares of the company's stock, valued at approximately $1,493,457.84. The disclosure for this sale can be found here. 1.90% of the stock is currently owned by company insiders.